These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 977795)
41. Evaluation of the clinical inequivalency of drug products of varying bioavailability. Barr WH; Adir J Ann Clin Res; 1974; 6(0):suppl 11:48-56. PubMed ID: 4605465 [No Abstract] [Full Text] [Related]
43. Use of bioavailability data by practitioners. Part 2: Preliminary report of evaluation skills of pharmacists and physicians. Vinson BE; Schumacher GE Am J Hosp Pharm; 1976 Nov; 33(11):1164-6. PubMed ID: 998634 [TBL] [Abstract][Full Text] [Related]
44. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. Bansinath M; Ghosh SS; Shafiqa A; Shukla VK; Chopra KS; Mathur VS Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):30-3. PubMed ID: 3957487 [TBL] [Abstract][Full Text] [Related]
45. Bioavailability of digoxin: what the clinician needs to know. Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW Conn Med; 1974 May; 38(5):230-2. PubMed ID: 4831099 [No Abstract] [Full Text] [Related]
46. Recent changes in biological availability of digoxin. Effect of an alteration in 'Lanoxin' tablets. Shaw TR; Howard MR; Hamer J Br Heart J; 1974 Jan; 36(1):85-9. PubMed ID: 4818143 [No Abstract] [Full Text] [Related]
48. [Editorial: Biologic availability--aspects related to general practice]. Schmidt R Schweiz Rundsch Med Prax; 1974 Jun; 63(23):697-8. PubMed ID: 4838647 [No Abstract] [Full Text] [Related]
49. Impact of the US FDA "Biopharmaceutics Classification System" (BCS) Guidance on Global Drug Development. Mehta MU; Uppoor RS; Conner DP; Seo P; Vaidyanathan J; Volpe DA; Stier E; Chilukuri D; Dorantes A; Ghosh T; Mandula H; Raines K; Dhanormchitphong P; Woodcock J; Yu LX Mol Pharm; 2017 Dec; 14(12):4334-4338. PubMed ID: 29076742 [TBL] [Abstract][Full Text] [Related]
50. Editorial: Bioavailability, bioequivalence and bias. Leopold IH Am J Ophthalmol; 1975 Mar; 79(3):518. PubMed ID: 1122003 [No Abstract] [Full Text] [Related]
51. [Biological availability of digoxin in combination drugs]. Gilfrich HJ; Clasen R Verh Dtsch Ges Inn Med; 1975; 81():1666-9. PubMed ID: 1227052 [No Abstract] [Full Text] [Related]
52. The bioavailability of digoxin. Lancet; 1972 Aug; 2(7772):311-2. PubMed ID: 4115037 [No Abstract] [Full Text] [Related]
55. Relative bioavailability of commercial ampicillin formulations in man. Mayersohn M; Endrenyi L Can Med Assoc J; 1973 Nov; 109(10):989-93. PubMed ID: 4758871 [TBL] [Abstract][Full Text] [Related]